The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3551-3575
Author(s):
H. Blasco, S. Mavel, P. Corcia and P.H. Gordon
Augmentation of Citalopram with Aspirin for Treating Major Depressive Disorder, a Double Blind Randomized Placebo Controlled Clinical Trial
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
13
Page:
108-111
Author(s):
Ahmad Ghanizadeh and Arvin Hedayati
Variability of Biological Activities of Limonoids Derived from Plant Sources
Journal:
Mini-Reviews in Organic Chemistry
Volume:
11
Page:
269-279
Author(s):
Pekala Jolanta, Strub Daniel Jan, Koziol Agata and Lochynski Stanislaw
Teratogenic Activity of HDAC Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5438-5442
Author(s):
Erminio Giavini and Elena Menegola
Therapeutic Drugs that Slow the Heart Rate of Early Rat Embryos. Is there a Risk for the Human?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5364-5376
Author(s):
William S Webster, Mats Nilsson and Helen Ritchie
Nitric Oxide and Teratogenesis: An Update
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5443-5447
Author(s):
Gian Mario Tiboni and Adalisa Ponzano
Zebrafish Model in Drug Safety Assessment
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5416-5429
Author(s):
Jyotshna Kanungo, Elvis Cuevas, Syed F. Ali and Merle G. Paule
Pharmacogenomics of Cardiovascular Complications in Diabetes and Obesity
Journal:
Recent Patents on Biotechnology
Volume:
8
Page:
123-135
Author(s):
Kalyan Chapalamadugu, Siva K. Panguluri, Aimon Miranda, Kevin B. Sneed and Srinivas M. Tipparaju
Conference Report: Summary Report of the International Association of Neurorestoratology VII Conference: Regulations, Ethics, Science, and the Need of Patients Care in Neurorestoratology
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
921-925
Author(s):
Lin Chen, Jiangfeng Guo, Alok Sharma, Aruna Sharma, Hari S. Sharma, Stephen D. Skaper and Hongyun Huang
The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1096-1119
Author(s):
Begona M. Escribano, Ana L. Colin-Gonzalez, Abel Santamaria and Isaac Tunez